Search alternatives:
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
de decrease » we decrease (Expand Search), _ decrease (Expand Search), nn decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
100 de » 100 due (Expand Search), 100 d (Expand Search)
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
de decrease » we decrease (Expand Search), _ decrease (Expand Search), nn decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
100 de » 100 due (Expand Search), 100 d (Expand Search)
-
241
Interspecific correlations in viral load between single and coinfections of CrPV and DCV.
Published 2023Subjects: -
242
-
243
-
244
-
245
-
246
-
247
-
248
-
249
-
250
-
251
dTTP excess causes a decrease of <i>in organello</i> mtDNA synthesis associated with secondary dCTP depletion.
Published 2011“…All results (except panel E) were obtained after 2 hours of <i>in organello</i> reaction. Bars represent mean±SD. A. Effect of an excess of each dNTP on mtDNA replication. …”
-
252
-
253
Ether induces proteotoxic stress, leading to a decrease in Trx protein and an increase in Hsp90 clients that are joint targets of Trx and Ubx.
Published 2024“…<b>(F)</b> Representative images of Acridine Orange-stained <i>yw</i> embryos for the following cases: no treatment (up left), 5-min immersion in Citrasolv solution [<a href="http://www.plosbiology.org/article/info:doi/10.1371/journal.pbio.3002629#pbio.3002629.ref046" target="_blank">46</a>] (up right), 5-min immersion in ether liquid (bottom right), and 1.5-h exposure to ether vapor (bottom left). …”
-
254
-
255
-
256
-
257
-
258
-
259
-
260
Discovery of a Colon-Targeted Azo Prodrug of Tofacitinib through the Establishment of Colon-Specific Delivery Systems Constructed by 5‑ASA–PABA–MAC and 5‑ASA–PABA–Diamine for the T...
Published 2022“…Specifically, compound <b>20g</b> displayed a 3.67-fold decrease of plasma AUC<sub>(tofacitinib, 0–∞)</sub> and a 9.61-fold increase of colonic AUC<sub>(tofacitinib, 0–12h)</sub>, compared with tofacitinib at a molar equivalent oral dose. …”